4
Changes in Ownership
Moderna, Inc. Filed Acc 0001127602-23-028862
Chief Legal Officer sold 111 shares at $79.31 ($8,804)
- Chief Legal Officer acquired 232 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klinger Shannon Thyme Chief Legal Officer | 2023-12-01 | Option exercise 10b5-1 | +232 | 7,447 | D: show line 1 in the form | ||
| Klinger Shannon Thyme Chief Legal Officer | 2023-12-04 | Sale 10b5-1 | −111 | $79.31 | $8,804 | 7,336 | D: show line 2 in the form |
| Open-market sales · 111 sh · avg $79.31 · $8,804 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Klinger Shannon Thyme Chief Legal Officer | 2023-12-01 | Option exercise · Restricted Stock Units 10b5-1 | −232 | 2,094 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…